Some of the first well designed clinical studies on Ivermectin are going to be coming out soon. One with over a 1,000, people and one with about 1,200 people.

The paper that kicked off the Ivermectin publicity was basically done in a petri dish. That's the very beginning of the road of medical studies. For one, things that might kill the virus in a petri dish might act different in the human body. For two, lots of things can kill cell in a petri dish, like battery acid are things you don't want in your body.

Once you have successful lab results you then need to have through multiple stages Phase 0, 1 and then Phase II and finally Stage III.

So have Stage III randomized, placebo-controlled, double-blind trial coming out on Ivermectin. Placebo controlled means some patients get Ivermectin and others get nothing. This is so you can compare taking the drug to doing nothing to see if there's significant different. A randomized double-blind study means neither the patient or the patient's doctor know if they are getting the drug or the placebo and who gets the drug is up to chance.

So we will soon have some solid data on Ivermectin.

There's an interesting theory about some of the results of previous studies in countries with bad water supplies. Ivermectin is used to treat parasites like worms. The drug now used with very sick Covid patients is corticosteriods. The theory is that the steriods might make the parasites more infectious and in that case Ivermectin would help. But in the US and other developed countries, parasitic worms are not much of an issue.

These might be published in the next couple of months.